SEC Form 4 · accession 0001019687-15-003480
International Stem Cell CORP · ISCO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mahnaz Ebrahimi
Officer — Chief Financial Officer
Period of report
Sep 14, 2015
Accepted (ET)
Sep 16, 2015 · 3:36 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001355790
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $2.75 | Sep 14, 2015 | A | 65,000 | A | — | Sep 14, 2025 | Common Stock | 65,000 | 65,000 | D |
Explanation of responses
- F150% of stock grant will be immediately exercisable (09/14/2015) the remaining 50% shares shall vest in equal monthly increments over the next 12 months.